Dear Members of the Englander Institute,Thank you all so much for another very successful and productive month!I hope you enjoy reading about May’s accomplishments, that include staff promotions, elections to professional committees, news...
Read more
Biomedical Engineering Symposium Showcases Research and Facilitates Collaborations A two-day intercampus event, the “Biomedical Engineering Symposium: Tools to Transform Discovery & Care,” recently brought together dozens of specialists in...
Read more
Nearly 90 percent of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to Weill Cornell...
Read more
The Bridge2AI-Voice Consortium, a program based on the NIH-funded study called Voice as a Biomarker of Health that is co-led by experts from Weill Cornell Medicine’s Englander Institute for Precision Medicine (EIPM) and the USF Health...
Read more
Dear Friend of the Englander Institute for Precision Medicine,Welcome to our first quarterly external newsletter of 2023!Thank you for signing up on our website to receive this newsletter, we hope you enjoy learning more about the important...
Read more
Dr. Ekta Khurana, an associate professor of physiology and biophysics at Weill Cornell Medicine, has received a 3-year, $1.2 million grant from the United States Department of Defense to investigate how prostate cancer cells evolve to become...
Read more
The Englander Institute for Precision Medicine’s Director Olivier Elemento, Ph.D. was recently interviewed by LDV Capital in advance of their 9th Annual LDV Vision Summit – “the premier global gathering in visual tech” – hosted...
Read more
Dr. Omar Abdul-Rahman, a leading specialist in pediatric genetic medicine, has been named chief of the Division of Medical Genetics in the Department of Pediatrics at Weill Cornell Medicine and NewYork-Presbyterian Komansky Children’s Hospital...
Read more
Obesity may spur DNA damage in the breast tissue of women who carry BRCA1 or BRCA2 mutations, possibly contributing to breast cancer development in this already high-risk group, according to new multi-institutional translational research led by...
Read more
March 2023 EIPM Director’s Memo Dear Friends, We just published a new animated video about the EIPM, which I hope you enjoy and will share with friends and colleagues! You can find it on our website, Twitter feed, Facebook page, and...
Read more
We hope you enjoy our new animated video and virtual tour of the EIPM labs by our Director Olivier Elemento, Ph.D. (@ElementoLab)! [Just click on the image below to watch the video!]
Read more
Five teams led by Weill Cornell Medicine scientists have been awarded funding from the Starr Cancer Consortium in its 16th annual grant competition. The grants will fund research on the molecular origins and evolution of blood, bladder, breast...
Read more